Heart Test Laboratories Stock Shares Owned By Insiders
| HSCS Stock | USD 3.01 0.33 9.88% |
Fundamental analysis of Heart Test allows traders to better anticipate movements in Heart Test's stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Heart Test Laboratories Company Shares Owned By Insiders Analysis
Heart Test's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Heart Test Shares Owned By Insiders | 3.49 % |
Most of Heart Test's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Heart Test Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 3.49% of Heart Test Laboratories are shares owned by insiders. This is 77.01% lower than that of the Health Care Equipment & Supplies sector and 77.56% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 65.41% higher than that of the company.
Heart Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Heart Test's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Heart Test could also be used in its relative valuation, which is a method of valuing Heart Test by comparing valuation metrics of similar companies.Heart Test is currently under evaluation in shares owned by insiders category among its peers.
Heart Fundamentals
| Return On Equity | -2.33 | ||||
| Return On Asset | -0.76 | ||||
| Operating Margin | (441.47) % | ||||
| Current Valuation | 10.38 M | ||||
| Shares Outstanding | 2.54 M | ||||
| Shares Owned By Insiders | 3.49 % | ||||
| Shares Owned By Institutions | 2.27 % | ||||
| Number Of Shares Shorted | 85.16 K | ||||
| Price To Book | 40.97 X | ||||
| Price To Sales | 1,946 X | ||||
| Revenue | 4.35 K | ||||
| Gross Profit | 2.47 K | ||||
| EBITDA | (8.14 M) | ||||
| Net Income | (8.77 M) | ||||
| Cash And Equivalents | 4.27 M | ||||
| Cash Per Share | 0.52 X | ||||
| Total Debt | 2.99 M | ||||
| Debt To Equity | 0.41 % | ||||
| Current Ratio | 3.53 X | ||||
| Book Value Per Share | 0.18 X | ||||
| Cash Flow From Operations | (7.41 M) | ||||
| Short Ratio | 0.83 X | ||||
| Earnings Per Share | (9.34) X | ||||
| Target Price | 13.5 | ||||
| Number Of Employees | 15 | ||||
| Beta | 2.59 | ||||
| Market Capitalization | 8.47 M | ||||
| Total Asset | 4.22 M | ||||
| Retained Earnings | (76.13 M) | ||||
| Working Capital | (1.53 M) | ||||
| Net Asset | 4.22 M |
About Heart Test Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Heart Test Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heart Test using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heart Test Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.